336 results on '"Dores, Graça M."'
Search Results
2. Use of Structured Electronic Health Records Data Elements for the Development of Computable Phenotypes to Identify Potential Adverse Events Associated with Intravenous Immunoglobulin Infusion
3. Trends in risk for therapy-related myelodysplastic syndrome/acute myeloid leukemia after initial chemo/immunotherapy for common and rare lymphoid neoplasms, 2000–2018
4. Hepatic veno-occlusive disease with asparaginase products: a review of cases reported to the FDA adverse event reporting system and published in the literature.
5. Patterns of red blood cell utilization: Harnessing electronic health records data from the Information Standard for Blood and Transplant (ISBT) 128 system within the Biologics Effectiveness and Safety (BEST) initiative
6. Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986–2019
7. Varicella zoster virus reactivation reported with isatuximab use.
8. Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
9. Risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after childhood cancer: a population-based study
10. Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000–2014
11. Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects
12. Case series of reports of pruritus and sipuleucel-T submitted to the Food and Drug Administration Adverse Event Reporting System
13. Immune globulin usage trends in commercially insured and Medicare populations, 2009–2019
14. Leukemias
15. U.S. Food and Drug Administration Analysis of Newly Identified Adverse Events With Lurbinectedin: Extravasation, Rhabdomyolysis, and Tumor Lysis Syndrome
16. Risks of therapy-related hematologic neoplasms beyond myelodysplastic syndromes and acute myeloid leukemia
17. Epidemiology and Hereditary Aspects of Acute Leukemia
18. Risks of therapy-related hematologic neoplasms beyond myelodysplastic syndromes and acute myeloid leukemia
19. Postmarketing Colitis Cases Associated With Alpelisib Use Reported to the US Food and Drug Administration
20. Association of Daratumumab Use With Ocular Events in a Case Series of US Adults
21. Retrospective benzene exposure assessment for a multi-center case-cohort study of benzene-exposed workers in China
22. Uncovering the Genetic Etiology of the (Posttherapy) Broken Heart
23. Radiation Dose and Subsequent Risk for Stomach Cancer in Long-term Survivors of Cervical Cancer
24. Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008
25. Benzene exposure and risk of benzene poisoning in Chinese workers
26. Benzene exposure and risk of benzene poisoning in Chinese workers
27. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007
28. Immune-Related Adverse Events After Immune Checkpoint Inhibitors for Melanoma Among Older Adults
29. Hemolytic anemia following alectinib reported to the U.S. Food and Drug Administration Adverse Event Reporting System
30. Safety surveillance of meningococcal group B vaccine (Bexsero®), Vaccine Adverse Event Reporting System, 2015–2018
31. A retrospective cohort study of cause-specific mortality and incidence of hematopoietic malignancies in Chinese benzene-exposed workers
32. Cause‐specific mortality following polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the US population, 2001–2017
33. Acute myocardial infarction: Development and application of an ICD-10-CM-based algorithm to a large U.S. healthcare claims-based database
34. Adverse events reported to the U.S. Food and Drug Administration Adverse Event Reporting System for tisagenlecleucel
35. Incidence of marginal zone lymphoma in the United States, 2001–2009 with a focus on primary anatomic site
36. The bidirectional increased risk of B-cell lymphoma and T-cell lymphoma
37. Cause-Specific Mortality Following Initial Chemotherapy in a Population-Based Cohort of Patients With Classical Hodgkin Lymphoma, 2000-2016
38. Epidemiology and Hereditary Aspects of Acute Leukemia
39. Incidence of potentially human papillomavirus–related neoplasms in the United States, 1978 to 2007
40. Autoimmune Disease and Subsequent Risk of Developing Alimentary Tract Cancers Among 4.5 Million US Male Veterans#
41. Melanoma of the skin and laterality
42. Safety Surveillance of Bivalent Meningococcal Group B Vaccine, Vaccine Adverse Event Reporting System, 2014–2018
43. Benzene exposure‐response and risk of lymphoid neoplasms in Chinese workers: A multicenter case‐cohort study
44. Potential underestimation of cerebrovascular events in the PROVENGE Registry for the Observation, Collection, and Evaluation of Experience Data
45. Cause‐specific mortality in individuals with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia, 2000–2016
46. Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999–2017
47. Safety review of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccines (Tdap) in adults aged ≥65 years, Vaccine Adverse Event reporting System (VAERS), United States, September 2010–December 2018
48. Primary cutaneous adenoid cystic carcinoma in the United States: Incidence, survival, and associated cancers, 1976 to 2005
49. Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors
50. Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.